Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 29;12(528):eaay0233.
doi: 10.1126/scitranslmed.aay0233.

Immune correlates of tuberculosis disease and risk translate across species

Affiliations

Immune correlates of tuberculosis disease and risk translate across species

Mushtaq Ahmed et al. Sci Transl Med. .

Abstract

One quarter of the world's population is infected with Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB). Although most infected individuals successfully control or clear the infection, some individuals will progress to TB disease. Immune correlates identified using animal models are not always effectively translated to human TB, thus resulting in a slow pace of translational discoveries from animal models to human TB for many platforms including vaccines, therapeutics, biomarkers, and diagnostic discovery. Therefore, it is critical to improve our poor understanding of immune correlates of disease and protection that are shared across animal TB models and human TB. In this study, we have provided an in-depth identification of the conserved and diversified gene/immune pathways in TB models of nonhuman primate and diversity outbred mouse and human TB. Our results show that prominent differentially expressed genes/pathways induced during TB disease progression are conserved in genetically diverse mice, macaques, and humans. In addition, using gene-deficient inbred mouse models, we have addressed the functional role of individual genes comprising the gene signature of disease progression seen in humans with Mtb infection. We show that genes representing specific immune pathways can be protective, detrimental, or redundant in controlling Mtb infection and translate into identifying immune pathways that mediate TB immunopathology in humans. Together, our cross-species findings provide insights into modeling TB disease and the immunological basis of TB disease progression.

PubMed Disclaimer

Conflict of interest statement

COMPETING FINANCIAL INTERESTS

T.J.S. is co-inventor of a patent (pending) of the 16-gene ACS signature. All other authors declare no competing financial interests.

Figures

Fig.1.
Fig.1.. Overview of the samples used and the computational analysis.
(A) Workflow of cross-species immune correlates of TB disease. (B) Mouse samples were divided into progressor and controller sample groups based on (Log10 bacterial burden) × (Log10 percentage lung inflammation), using thresholds of < 6.5 and > 8.5, respectively, (C) PCA clustering of the mouse RNA-Seq samples based on the default DESeq2 method (top 500 most variable genes) and (D) PCA clustering of the macaque RNA-Seq samples.
Fig.2.
Fig.2.. Conserved differentially expressed genes in controllers and progressors.
The counts of overlapping significantly differentially expressed genes between mouse genes, macaque genes and human genes (7) are shown for (A) genes higher in controller and (B) genes higher in progressor. Shaded areas represent gene sets used for REACTOME enrichment testing, as shown in panels (C) for genes higher in controller and (D) for genes higher in progressor. *Gene sets visualized in Fig.3.
Fig.3.
Fig.3.. Differentially expressed genes that are significantly different in TB controllers across species.
(A) Higher in controller vs progressor and naive in mouse, and higher in controller vs progressor in macaque and human; (B) lower in controller vs progressor and naive in both mouse and macaque; (C) higher in progressor vs controller and naive in both mouse and macaque, and higher in progressor vs controller in mouse (includes ACS signature genes and top 10 most significant other genes); (D) lower in progressor vs controller and naive in both mouse and macaque and lower in progressor vs controller in mouse (top 10 most significant shown).
Fig.4.
Fig.4.. Expression of the 16-gene ACS signature genes across species.
(A) Ortholog gene expression of 13 out of 16 human ACS signature genes (7) in progressor versus controller, progressor versus naive and controller versus naive, in mouse and macaque. Note that both FCGR1A and FCGR1B are represented by a single gene in mice and macaques, and human ETVTs ortholog in mouse is called Etv6. (B) SCARF1 expression in progressor, controller versus naive in mouse and macaque is shown. (C) SEPT4 expression in progressor, controller and naive is shown in mouse and macaque. All P values shown on the expression swarm plots represent FDR-corrected significance values for differential expression calculated by DESeq2.
Fig.5.
Fig.5.. Genes in the 16-gene ACS signature that mediate protective immune responses in the mouse model.
Control or gene deficient mice were infected with Mtb HN878 (100 CFU) by aerosol route. On 30, 60 and 100 days post-infection (dpi), lungs were harvested to assess bacterial burden by plating, or inflammatory cell infiltration by flow cytometry, or histologically by H&E staining in (A) Statt−/− mice (B) Tap1−/− mice, (C) GbpChr3−/− mice (D) Trafdt−/− mice and (E) Sept4−/− mice and relevant controls are shown. The data points represent the means (±SEM) of one out of two separate experiments. Significance for bacterial burden analysis for C57BL/6 and gene deficient mice was determined using unpaired two-tailed Student’s t-test at different dpi.
Fig.6.
Fig.6.. Genes in the 16-gene ACS signature that mediate detrimental effects during infection.
Wild-type or gene-deficient mice strains were infected with Mtb HN878 (100 CFU) by aerosol route. On 30, 60, 100 and 120 days post-infection (dpi), lungs were harvested to assess bacterial burden by plating, or inflammatory cell infiltration by flow cytometry, or histologically by H&E staining in (A) Batf2/3r−/− mice, (B) Fcgrt−/− mice (C) Scarft−/− mice and relevant controls (D) DESeq2 differential gene expression comparisons identified in infected Scarft−/− mice compared to wild-type mice at 120 dpi respectively, (E) Gene set enrichment analysis (GSEA) for Reactome pathways significantly enriched among human proteins with high correlation to SCARF1. Enrichment plots are shown for each of the enriched terms, showing the relative rank of genes from the enriched pathways (across the x-axis) and (F) IL-10 and TNFa production was measured in culture supernatants from uninfected and Mtb HN878-infected bone marrow derived macrophages (MOI 1) from C57BL/6J and ScarfT−/− mice after 2 dpi. The data points represent the means (±SEM) of one out of two separate experiments. Bacterial burden in gene deficient mice compared to control mice and cytokine production from macrophages was done by unpaired two-tailed Student’s t-test at different dpi.

References

    1. Flynn JL, Lessons from experimental Mycobacterium tuberculosis infections. Microbes and Infection 8, 1179–1188 (2006). - PubMed
    1. Kagina BM, Abel B, Scriba TJ, Hughes EJ, Keyser A, Soares A, Gamieldien H, Sidibana M, Hatherill M, Gelderbloem S, Mahomed H, Hawkridge A, Hussey G, Kaplan G, Hanekom WA, other members of the South African Tuberculosis Vaccine, Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns. American journal of respiratory and critical care medicine 182, 1073–1079 (2010). - PMC - PubMed
    1. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T, Wilkinson KA, Banchereau R, Skinner J, Wilkinson RJ, Quinn C, Blankenship D, Dhawan R, Cush JJ, Mejias A, Ramilo O, Kon OM, Pascual V, Banchereau J, Chaussabel D, O’Garra A, An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973–977 (2010). - PMC - PubMed
    1. Kaforou M, Wright VJ, Oni T, French N, Anderson ST, Bangani N, Banwell CM, Brent AJ, Crampin AC, Dockrell HM, Eley B, Heyderman RS, Hibberd ML, Kern F, Langford PR, Ling L, Mendelson M, Ottenhoff TH, Zgambo F, Wilkinson RJ, Coin LJ, Levin M, Detection of Tuberculosis in HIV-Infected and -Uninfected African Adults Using Whole Blood RNA Expression Signatures: A Case-Control Study. PLOS Medicine 10, e1001538 (2013). - PMC - PubMed
    1. Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, Black G, Walzl G, Kaufmann SH, Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes and immunity 12, 15–22 (2011). - PubMed